Osteoblast-specific transcription factor Osterix (Osx) and HIF-1α cooperatively regulate gene expression of vascular endothelial growth factor (VEGF)

Biochemical and Biophysical Research Communications

Volumn 424, Issue 1, 2012, Pages 176-181

  Chen, Dafu ^a   Tian, Wei ^a   Li, Yang ^b   Tang, Wanjin ^b   Zhang, Chi ^b,c  

^a Beijing Jishuitan Hospital   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; BMP 2; Bone formation; Dox; E18.5; GAPDH; HIF 1 ; Osteogenesis; Osterix; Osx; PRR; VEGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MUTANT PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR OSTERIX; VASCULOTROPIN;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CALVARIA; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROLINE RICH PROTEIN DOMAIN; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROLINE-RICH PROTEIN DOMAINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864088681     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.104     Document Type: Article

References (17)

1. Zhang C. Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx. J. Orthop. Surg. Res. 2010, 5:37.
2. St-Jacques B., Hammerschmidt M., McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 1999, 13:2072-2086.
3. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
4. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
5. Zhang C., Cho K., Huang Y., Lyons J.P., Zhou X., Sinha K., McCrea P.D., de Crombrugghe B. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6936-6941.
6. Wan C., Shao J., Gilbert S.R., Riddle R.C., Long F., Johnson R.S., Schipani E., Clemens T.L. Role of HIF-1alpha in skeletal development. Ann. N. Y. Acad. Sci. 2010, 1192:322-326.
7. Dai J., Rabie A.B. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J. Dent. Res. 2007, 86:937-950.
8. Furumatsu T., Shen Z.N., Kawai A., Nishida K., Manabe H., Oohashi T., Inoue H., Ninomiya Y. Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. J. Biochem. 2003, 133:633-639.
9. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 1999, 5:623-628.
10. Wang Y., Wan C., Deng L., Liu X., Cao X., Gilbert S.R., Bouxsein M.L., Faugere M.C., Guldberg R.E., Gerstenfeld L.C., Haase V.H., Johnson R.S., Schipani E., Clemens T.L. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest. 2007, 117:1616-1626.
11. Kotch L.E., Iyer N.V., Laughner E., Semenza G.L. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. 1999, 209:254-267.
12. Tang W., Yang F., Li Y., de Crombrugghe B., Jiao H., Xiao G., Zhang C. Transcriptional regulation of vascular endothelial growth factor (VEGF) by osteoblast-specific transcription factor osterix (Osx) in osteoblasts. J. Biol. Chem. 2012, 287:1671-1678.
13. Schipani E., Maes C., Carmeliet G., Semenza G.L. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J. Bone Miner. Res. 2009, 24:1347-1353.
14. Zhang C., Yang F., Cornelia R., Tang W., Swisher S., Kim H. Hypoxia-inducible factor-1 is a positive regulator of Sox9 activity in femoral head osteonecrosis. Bone 2011, 48:507-513.
15. Zelzer E., Mamluk R., Ferrara N., Johnson R.S., Schipani E., Olsen B.R. VEGFA is necessary for chondrocyte survival during bone development. Development 2004, 131:2161-2171.
16. Zelzer E., Glotzer D.J., Hartmann C., Thomas D., Fukai N., Soker S., Olsen B.R. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 2001, 106:97-106.
17. Street J., Bao M., de Guzman L., Bunting S., Peale F.V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J.L., Daugherty A., van Bruggen N., Redmond H.P., Carano R.A., Filvaroff E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9656-9661.